VRDN Stock Analysis: Buy, Sell, or Hold?
VRDN - Viridian Therapeutics, Inc. Common Stock
$19.40
0.92 (4.98%)
▲
5d:
+11.56%
30d:
+22.24%
90d:
+1.31%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.0/10
Get Alerted When VRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: VRDN is 7.9% above its trading range ($17.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: VRDN is 7.9% above its trading range ($17.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: VRDN is currently trading at $19.40, which is considered extended relative to its 30-day fair value range of $16.05 to $17.98.
Technical Outlook: Technically, VRDN is in a strong uptrend. The price is approaching resistance at $19.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: VRDN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $36.12 (+86.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRDN is in a strong uptrend. The price is approaching resistance at $19.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: VRDN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $36.12 (+86.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.05 -
$17.98
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
Protect Your Profits
Holding VRDN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.9% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 86.2% below Wall St target ($36.12)
- CAUTION: Extended 7.9% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$16.05 -
$17.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.46
Resistance Level
$19.53
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.59
Wall Street Target
$36.13
(+86.2%)
Revenue Growth (YoY)
95.8%
Share & Embed Analysis
Last updated: July 02, 2026 10:33 PM ET
Data refreshes hourly during market hours. Next update: 11:33 PM
Data refreshes hourly during market hours. Next update: 11:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
Advanced VRDN Option Strategies
Professional options setups generated by AI based on today's VRDN price and gamma walls.
